GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vineet Laboratories Ltd (BOM:543298) » Definitions » YoY EBITDA Growth

Vineet Laboratories (BOM:543298) YoY EBITDA Growth : -132.20% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Vineet Laboratories YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Vineet Laboratories's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -132.20%.

Vineet Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was ₹-0.68.


Vineet Laboratories YoY EBITDA Growth Historical Data

The historical data trend for Vineet Laboratories's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vineet Laboratories YoY EBITDA Growth Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY EBITDA Growth
Get a 7-Day Free Trial - - 71,691.67 62.25 -45.05

Vineet Laboratories Quarterly Data
Mar17 Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.76 -6.87 -92.88 244.80 -132.20

Vineet Laboratories YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Vineet Laboratories's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (A: Mar. 2023 )
=(EBITDA per Share (A: Mar. 2023 )-EBITDA per Share (A: Mar. 2022 ))/ | EBITDA per Share (A: Mar. 2022 ) |
=(7.659-13.939)/ | 13.939 |
=-45.05 %

Vineet Laboratories's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.682-2.118)/ | 2.118 |
=-132.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vineet Laboratories YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Vineet Laboratories's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Vineet Laboratories (BOM:543298) Business Description

Traded in Other Exchanges
Address
5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre, Chintalakunta, L.B.Nagar, Hyderabad, TG, IND, 500 074
Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.

Vineet Laboratories (BOM:543298) Headlines

No Headlines